搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
5 小时
Robbie Williams heartbreakingly admits he's not dealing with his parents' devastating ill ...
The singer, 50, revealed earlier this year that his mother Janet had been diagnosed with dementia, four-years after his ...
11 小时
Miami-Dade County approves $3.6 million incentive deal for new data center
The funding comes from a county program that offers cash to businesses that want to expand locally and add at least 10 new ...
来自MSN
13 小时
Denali Starts Dosing in Phase II Parkinson's Disease Study
Denali Therapeutics Inc. DNLI initiated dosing in a global mid-stage study, BEACON, on BIIB122 (DNL151). BIIB122, an ...
The Nation Newspaper
22 小时
NGO hosts walking football tourney for Parkinson’s victims
The 5-a-side match, which was held at the Eagle Club, Surulere, Lagos last weekend was in collaboration with Parkinson’s ...
ScienceAlert on MSN
1 天
New Drug May Prevent Cognitive Decline in Parkinson's Disease
A decline in motor skills is a hallmark of Parkinson's disease, regularly taking the form of slowness, rigidity, and tremors.
Outsourcing-pharma
1 天
Mitsubishi teams up with Dewpoint in $480m ALS deal
As part of the deal, Dewpoint can expect an undisclosed upfront payment from Mitsubishi Tanabe Pharma Corporation (MTPC) in ...
2 天
Medical Moment: ImPULS controls Parkinson’s tremors
Although there is no cure, there are ways to relieve the tremors, stiffness, depression, anxiety, and memory problems caused ...
2 天
Yale marks construction milestone at $838M neuroscience center in New Haven
Construction workers and others look on as crews install the final beam for the $838 million, 500,000 square foot, ...
GEN
2 天
Gene and Cell Therapies Take Aim at Parkinson’s Disease
New therapies that are less intrusive but more lasting than current interventions promise to arrest and even reverse neurodegeneration.
TMCnet
3 天
Spur Therapeutics Announces Development Candidate in Parkinson's Disease Gene Therapy Program
Spur Therapeutics today announced that it has selected a lead development candidate in its gene therapy program for a genetically defined subset of Parkinson’s disease characterized by mutations in ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈